3650 results for «248»

Filter By

3650 results

!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice

20 Nov 2023 – From PCR London Valves 2023

Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.

!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice

TAVI with a new generation of valve and difficult arterial access - LIVE case

07 Dec 2023 – From GulfPCR-GIM 2023

An 84-year-old woman with type 2 diabetes, anaemia (Hgb: 9 g/dl), morbid obesity and limited mobility, and mild LV function impairment (50%), presented an acute heart failure on severe aortic valve stenosis.
The operators decided to implant an Evolut FX by femoral access with secondary access in...

Contemporary TAVI in 2023

Lifetime management - Tailoring treatment options to secure future possibilities

07 Dec 2023 – From GulfPCR-GIM 2023

Discover key insights in this video session from GulfPCR-GIM 2023 focusing on post-TAVI considerations. Gain understanding into the importance of posterior left ventricular and conduction disorders after TAVI and their impact on long-term outcomes. Explore the latest evidence regarding lifetime management for aortic stenosis patients. Delve...

Lifetime management - Tailoring treatment options to secure future possibilities

Left main stenting: one vs. two stent strategy

06 Dec 2023 – From GulfPCR-GIM 2023

In these selected clinical cases, discover strategies on whether to choose one or two stents in the case of left main disease. Explore the use of effective imaging, IABP, and other mechanical support devices.

Challenging cases – Best case submissions

07 Dec 2023 – From GulfPCR-GIM 2023

Explore catheter intervention for mechanical valve thrombosis, understand severe chest pain and shock in a young female patient, discover iatrogenic left main coronary artery type F dissection, address refractory ascites transitioning from internal medicine to interventional cardiology, and witness a narrowly avoided rotablation nightmare in this...

Challenging cases – Best case submissions

GulfPCR-GIM 2023 Closing Ceremony

07 Dec 2023 – From GulfPCR-GIM 2023

There is no better way to close this 2023 edition of GulfPCR-GIM than to start by thanking the clinical case and abstract authors for their submissions, before revealing the best ones and rewarding the winners. Then it's time to review this year's event by presenting the key...

GulfPCR-GIM 2023 Closing Ceremony

Tailored approaches to complex bifurcation PCI: part 1

06 Dec 2023 – From GulfPCR-GIM 2023

This session focuses on PCI approaches to complex bifurcation. Learn more about the use of TAP technique, provisional stenting in a trifurcation, and complex multivessel PCI through the lens of a selection of cases.

Rapid-fire - Nightmares in the cathlab - Part 3

21 Nov 2023 – From PCR London Valves 2023

Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...

Rapid-fire - Nightmares in the cathlab - Part 3

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Nicola Ryan

Author

Nicola Ryan
RESHAPE-HF2

Insights from the Corevalve US Pivotal and SURTAVI trials

05 Apr 2022

Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.

Pierre Deharo

Author

Pierre Deharo
Giuseppe Di Gioia

Author

Giuseppe Di Gioia
Insights From the Corevalve US Pivotal and SURTAVI Trials
Didn’t find what you were looking for?